Brief: Mersana Therapeutics Q1 EPS USD -0.19
15/05/2025 12:01
May 15 (Reuters) - Mersana Therapeutics Q1 collaboration revenue USD 2.754 million. Q1 net income USD -24.123 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m